Technology
Health
Biotechnology

XOMA

$12.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.28 (2.23%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell XOMA and other stocks, options, ETFs, and crypto commission-free!

About

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. Read More The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Employees
11
Headquarters
Emeryville, California
Founded
1981
Market Cap
108.98M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
94.97K
High Today
$13.00
Low Today
$12.40
Open Price
$12.59
Volume
48.35K
52 Week High
$25.99
52 Week Low
$11.02

Collections

Technology
Health
Biotechnology
Therapy
US
North America

News

Markets InsiderMar 7

XOMA Reports Fourth Quarter and Full Year 2018 Financial Results and Operating Highlights

Added seven new partner-funded programs in 2018 with potential for milestone and royalty payments Current cash balance sufficient to fund operations for multiple years EMERYVILLE, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) announced its fourth quarter and full-year 2018 financial results and business highlights. “In 2018, we completed the first transaction under our royalty-aggregator business model, adding seven assets being developed by Merck and Incyte, bringing our roy...

44
Associated PressMar 5

XOMA to Present at the Cowen and Company 39th Annual Health Care Conference

EMERYVILLE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the Cowen and Company 39th Annual Health Care Conference in Boston, Massachusetts. The presentation will take place on Tuesday, March 12, 2019, at 12:00PM ET, and can be accessed via a live webcast on the investor relations page of XOMA’s website at www.xoma.com. An archived version of the webcast will be availabl...

6

Earnings

-$1.54
-$0.91
-$0.29
$0.34
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 9, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.